Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating activities:
Net income	$ 42,988	$ 19,672
Loss (income) from discontinued operations	16,046	(961)
Income from continuing operations	59,034	18,711
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	7,652	8,547
Amortization and adjustments to operating lease assets	27,057	21,309
Depreciation	18,325	17,224
Amortization of intangible assets	5,037	5,110
Amortization of deferred debt issuance costs	828	783
Provision for bad debts	5,377	11,436
Deferred income taxes	(583)	2,067
Loss on disposals, accelerated depreciation, and adjustments to property and equipment	1,593	1,100
Realized and unrealized gain on investments	(1,524)	(442)
Realized gain on sale of assets	0	(4,779)
Unrealized loss on derivative	0	28,006
Changes in assets and liabilities:
Accounts receivable	(6,698)	(14,779)
Prepaid expenses and other current assets	5,517	(19,445)
Accounts payable	2,701	(20,906)
Accrued payroll and benefits	(9,832)	(7,576)
Accrued liabilities	1,758	(916)
Deferred revenue	5,811	(44,531)
Operating lease liabilities	(24,962)	(27,549)
Other assets and liabilities	(11,805)	2,390
Net cash provided by (used in) operating activities-continuing operations	85,286	(24,240)
Net cash (used in) provided by operating activities-discontinued operations	(21,893)	10,566
Net cash provided by (used in) operating activities	63,393	(13,674)
Investing activities:
Capital expenditures	(24,175)	(20,311)
Proceeds from sales of marketable securities	1,565	702
Purchases of marketable securities	(1,613)	(753)
Proceeds from sale of assets	0	6,421
Cash received on purchase price adjustment	0	92
Net cash used in investing activities-continuing operations	(24,223)	(13,849)
Net cash used in investing activities-discontinued operations	0	(2,585)
Net cash used in investing activities	(24,223)	(16,434)
Financing activities:
Proceeds from exercise of stock options	56	2,028
Employee taxes paid on withholding shares	(4,073)	(5,232)
Proceeds from stock issued under Colleague Stock Purchase Plan	83	0
Repurchases of common stock for treasury	(44,963)	(100,019)
Borrowings under credit facility	0	160,000
Repayments under credit facility	(1,500)	(146,500)
Proceeds from down payment on seller loan	0	5,200
Payment for purchase of redeemable noncontrolling interest of subsidiary	0	(6,247)
Payment of debt issuance costs	(1,722)	0
Net cash used in financing activities-continuing operations	(52,119)	(90,770)
Net cash used in financing activities-discontinued operations	0	(1,765)
Net cash used in financing activities	(52,119)	(92,535)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	565	(3,037)
Net decrease in cash, cash equivalents and restricted cash	(12,384)	(125,680)
Cash, cash equivalents and restricted cash at beginning of period	501,105	300,467
Cash, cash equivalents and restricted cash at end of period	488,721	174,787
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period	0	104,040
Cash, cash equivalents and restricted cash at end of period	$ 488,721	$ 70,747